Zurich Cantonal Bank’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.25M Sell
60,185
-5,955
-9% -$322K 0.01% 754
2026
Q1
$3.46M Buy
66,140
+21,175
+47% +$1.27M 0.01% 783
2025
Q4
$2.64M Buy
44,965
+11,232
+33% +$682K 0.01% 833
2025
Q3
$1.88M Buy
33,733
+2,171
+7% +$116K ﹤0.01% 947
2025
Q2
$1.62M Sell
31,562
-2,443
-7% -$123K ﹤0.01% 966
2025
Q1
$1.99M Buy
34,005
+249
+0.7% +$16.9K 0.01% 825
2024
Q4
$2.43M Sell
33,756
-979
-3% -$71.9K 0.01% 774
2024
Q3
$2.78M Buy
34,735
+6,462
+23% +$486K 0.01% 710
2024
Q2
$2.03M Buy
28,273
+482
+2% +$35.5K 0.01% 751
2024
Q1
$1.96M Sell
27,791
-247
-0.9% -$17.7K 0.01% 768
2023
Q4
$2.16M Buy
28,038
+3,559
+15% +$234K 0.01% 717
2023
Q3
$1.67M Buy
24,479
+1,644
+7% +$130K 0.01% 761
2023
Q2
$1.86M Buy
22,835
+563
+3% +$45.3K 0.01% 726
2023
Q1
$1.65M Hold
22,272
0.01% 733
2022
Q4
$1.85M Sell
22,272
-60
-0.3% -$4.76K 0.01% 690
2022
Q3
$1.59M Buy
22,332
+2,260
+11% +$195K 0.01% 724
2022
Q2
$1.74M Sell
20,072
-13,916
-41% -$1.3M 0.01% 706
2022
Q1
$3.68M Hold
33,988
0.02% 586
2021
Q4
$4.4M Sell
33,988
-2,384
-7% -$292K 0.02% 572
2021
Q3
$4.41M Buy
36,372
+436
+1% +$53.1K 0.02% 552
2021
Q2
$4.04M Buy
35,936
+20,288
+130% +$2.14M 0.02% 540
2021
Q1
$1.49M Sell
15,648
-2,736
-15% -$250K 0.01% 769
2020
Q4
$1.46M Buy
18,384
+856
+5% +$62K 0.01% 829
2020
Q3
$1.09M Buy
17,528
+816
+5% +$53.1K 0.01% 829
2020
Q2
$1.1M Buy
16,712
+3,632
+28% +$218K 0.01% 772
2020
Q1
$620K Buy
13,080
+2,592
+25% +$130K 0.01% 837
2019
Q4
$576K Buy
10,488
+1,236
+13% +$64.8K ﹤0.01% 892
2019
Q3
$453K Hold
9,252
﹤0.01% 927
2019
Q2
$482K Buy
9,252
+424
+5% +$21.4K ﹤0.01% 922
2019
Q1
$438K Sell
8,828
-1,608
-15% -$72.4K ﹤0.01% 916
2018
Q4
$378K Buy
10,436
+952
+10% +$39.8K ﹤0.01% 957
2018
Q3
$484K Buy
9,484
+500
+6% +$22.1K ﹤0.01% 935
2018
Q2
$332K Sell
8,984
-1,664
-16% -$63.5K ﹤0.01% 1014
2018
Q1
$402K Buy
10,648
+2,372
+29% +$83.8K ﹤0.01% 915
2017
Q4
$268K Buy
8,276
+2,452
+42% +$77.9K ﹤0.01% 1037
2017
Q3
$176K Hold
5,824
﹤0.01% 1073
2017
Q2
$171K Buy
5,824
+652
+13% +$17.8K ﹤0.01% 1069
2017
Q1
$131K Hold
5,172
﹤0.01% 1178
2016
Q4
$133K Hold
5,172
﹤0.01% 1134
2016
Q3
$142K Buy
5,172
+612
+13% +$16.8K ﹤0.01% 1051
2016
Q2
$129K Hold
4,560
﹤0.01% 1032
2016
Q1
$108K Hold
4,560
﹤0.01% 1089
2015
Q4
$103K Buy
4,560
+2,620
+135% +$59.7K ﹤0.01% 1123
2015
Q3
$45K Buy
1,940
+1,192
+159% +$29.9K ﹤0.01% 1146
2015
Q2
$18K Hold
748
﹤0.01% 1134
2015
Q1
$19K Buy
+748
New +$17.8K ﹤0.01% 1118

Other funds holding TECH

Zurich Cantonal Bank's TECH Position: Q2 2026 in Review

Zurich Cantonal Bank reduced its Bio-Techne (TECH) stake by 9% in Q2 2026, selling an estimated $322K and leaving 60,185 shares worth $4.25M. The position accounts for 0.01% of the portfolio, ranked #754.

Zurich Cantonal Bank first reported a position in TECH in Q1 2015 and has held it in 46 quarters since. The position peaked at $4.41M in Q3 2021. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Zurich Cantonal Bank held 60,185 shares of Bio-Techne worth $4.25M as of Q2 2026.
  • Zurich Cantonal Bank sold 5,955 Bio-Techne shares in Q2 2026, an estimated $322K.
  • Bio-Techne made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #754 holding.
  • Zurich Cantonal Bank first reported a position in Bio-Techne in Q1 2015 and has held it in 46 quarters since.
  • Zurich Cantonal Bank's Bio-Techne position peaked at $4.41M in Q3 2021.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.